6th Annual Drug Development Congress 2014 Geneva

  • Conference Call
  • Oxford Global Con­fer­ences are pleased to announce the 6th Annual Drug Devel­op­ment Con­gress 2014, tak­ing place at the Inter­con­ti­nen­tal Geneva in Geneva, Switzer­land on 2 & 3 June.

    It is esti­mated that less than 10% of drug devel­op­ment pro­grammes result in safe and effi­ca­cious ther­a­pies. This con­gress brings together a host of drug devel­op­ment experts to dis­cuss how we can strengthen the link between inno­v­a­tive sci­ence and clin­i­cal success.

    Day One of the con­gress cov­ers key advances in pre­dic­tive sci­ence, such as stem cell tech­nolo­gies for pre­dic­tive mod­el­ing and novel bio­marker tech­nol­ogy for safety pre­dic­tion. Speak­ers will dis­cuss meth­ods of achiev­ing phys­i­o­log­i­cally rel­e­vant mod­els and com­pare strate­gies for tack­ling pre­dic­tive chal­lenges, such as com­plex bio­log­ics and multi-​target drugs.

    Day Two of the con­gress looks at the way trans­la­tional research can unlock the poten­tial of early stage pipelines. Pre­sen­ta­tions will explore ways of har­mon­is­ing ADMET strat­egy in dis­cov­ery and devel­op­ment, inte­grat­ing tox­i­col­ogy prac­tices through­out the pipeline and improv­ing the use of imag­ing in trans­la­tional research. Del­e­gates will also hear case stud­ies con­cern­ing key tools for trans­la­tional med­i­cine, includ­ing novel immunoas­says, resis­tance bio­mark­ers and quan­ti­ta­tive sci­ence applications.

    The con­gress is part of the 15th Annual Drug Dis­cov­ery Sum­mit – Europe’s pre­mier net­work­ing and dis­cus­sion forum for phar­ma­ceu­ti­cal lead­ers. The con­gress is also co-​located with the 2nd Annual Dis­cov­ery Chem­istry and Drug Design Con­gress 2014.

    Agenda

    Day 1: Pre­dic­tive Science

    • Stem cell tech­nol­ogy for effec­tive pre­dic­tive modeling
    • Immuno­genic­ity pre­dic­tion and mitigation
    • Pre­dic­tive bio­mark­ers: devel­op­ment and validation
    • IVIVCS: bridg­ing the gap between in vitro and in vivo
    • Safety pre­dic­tion: novel bio­marker tech­nol­ogy, genetic vari­a­tion studies
    • Pre­dic­tive sci­ence in co-​medication research
    • Exploratory tox­i­col­ogy and mech­a­nism based tox­i­c­ity testing
    • Pre­dic­tive chal­lenges: com­plex bio­log­ics and multi-​target action

    Day 2: Trans­la­tional Medicine

    • The role of imag­ing tech­nol­ogy in trans­la­tional medicine
    • Har­mon­is­ing ADMET strat­egy in dis­cov­ery and development
    • Inte­grat­ing tox­i­col­ogy prac­tices through­out the pipeline
    • New tools for trans­la­tional med­i­cine: novel immunoas­says, resis­tance bio­mark­ers, tox­i­coge­nomic applications
    • PK/​PD – improv­ing deci­sion mak­ing from can­di­date selec­tion to clin­i­cal trial
    • Quan­ti­ta­tive sci­ence: the build­ing block of trans­la­tional medicine?

    Con­fer­ence Skeapers

    • Philip M. Arlen – Pres­i­dent & CEO, Pre­ci­sion Biologics
    • Joerg Bluemel – Direc­tor Bio­log­ics Safety Assess­ment, Trans­la­tional Sci­ences, MedImmune
    • Roberta Bursi – Senior Direc­tor Global Bio­met­rics, Head of Phar­ma­co­met­rics, Grünenthal
    • Donna Dambach – Direc­tor, Direc­tor, Small Mol­e­cule & Inves­tiga­tive Tox­i­col­ogy, Genentech
    • Hugues Dol­gos – Senior Direc­tor, Global Early Devel­op­ment, Trans­la­tional Med­i­cine Strat­egy Imple­men­ta­tion Leader, Merck Serono
    • Pamela Gar­zone – Exec­u­tive Direc­tor Biotech­nol­ogy Clin­i­cal Research, Pfizer
    • Man­fred Kansy – Head Sci­ence and Tech­nol­ogy Strat­egy in Non-​Clinical Safety, Roche
    • Stephan Kirch­ner – Head Dis­cov­ery Geno­tox­i­c­ity and In Vitro Pho­to­tox­i­c­ity, Roche
    • Thierry Lave – Head DMPK Mod­el­ing and Sim­u­la­tion, Roche
    • Mag­nus Ord – Global Sec­tion Direc­tor Safety Sci­ence, AstraZeneca
    • Vito Sas­seville – Exec­u­tive Direc­tor, Pre­clin­i­cal Safety: Dis­cov­ery & Inves­tiga­tive Safety, Novartis

    Sub­mit a poster

    For atten­dees inter­ested in sub­mit­ting a poster, there are oppor­tu­ni­ties now avail­able. Your poster pre­sen­ta­tion will be located in the exhi­bi­tion room for two days along­side other posters from senior sci­en­tists work­ing in indus­try and academia.

    How to sub­mit your poster

    We will require:

    • Poster title, Abstract (200 words or less)
    • Prin­ci­pal author, Organisation
    • Mail­ing address, Email, Tele­phone, Fax
    • Addi­tional authors

    In order to secure your board space a fee of £125 will be required. The poster should be pre­sented as A0 (841mm x 1189mm) por­trait size.

    To take advan­tage of this oppor­tu­nity you need to be reg­is­tered as a paid del­e­gate over the 2 days. We have lim­ited spaces available,so please reg­is­ter soon!

    Who Will Attend

    The 6th Annual Drug Devel­op­ment Con­gress is an exclu­sive event designed for senior level atten­dees from lead­ing phar­ma­ceu­ti­cal and biotech­nol­ogy organ­i­sa­tions, along with highly esteemed mem­bers of aca­d­e­mic and gov­ern­ment institutions.

    Del­e­gates typ­i­cally include VPs, Direc­tors and Global Heads of:

    • ADMET
    • Assay devel­op­ment
    • Bio­mark­ers
    • Bio­phar­ma­ceu­ti­cals
    • DMPK
    • Imag­ing
    • Mod­el­ing & simulation
    • Phar­ma­col­ogy
    • PK/​PD
    • Pre­dic­tive science
    • Research & development
    • Safety
    • Tox­i­col­ogy
    • Trans­la­tional medicine

    Del­e­gates will ben­e­fit from…

    • An exec­u­tive for­mat that facil­i­tates idea exchange and dis­cus­sion of rel­e­vant expe­ri­ences through case study pre­sen­ta­tions and strate­gic discussions
    • Net­work­ing oppor­tu­ni­ties and knowl­edge share with highly-​esteemed peers
    • Pre-​scheduled one-​to-​one meet­ings with solu­tion providers offer­ing an oppor­tu­nity to forge part­ner­ships and dis­cover inno­v­a­tive solutions
    • Post event fol­low up pro­vid­ing all doc­u­men­ta­tion from the meet­ing and re-​booking discounts
    • Tailor-​made agenda – hand pick any con­fer­ence and panel ses­sions you wish to attend
    starting: ending: 03.06.2014 Location: , Category:

    Timeline

    Conference START 03.06.2014 END

    All deadlines have expired!

    This conference has no more open deadlines. There may be successive conferences coming up you may by interested in.

    Please check our conference list and search...

    Conference Facts

    Location , Address InterContinental Geneva, Chemin du Petit-Saconnex 7-9 Category Organiser More Info Conference Website

    Further interesting Conferences

    Currently we have no similar events listed. Please check our website regulary, subscribe to our RSS-Feed or follow us on twitter for new listings.